Rigel Pharmaceuticals
RIGL
RIGL
191 hedge funds and large institutions have $690M invested in Rigel Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 65 increasing their positions, 62 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
14% more funds holding
Funds holding: 168 → 191 (+23)
5.1% more ownership
Funds ownership: 83.75% → 88.85% (+5.1%)
5% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 62
Holders
191
Holding in Top 10
2
Calls
$7.71M
Puts
$1.84M
Top Buyers
| 1 | +$20.2M | |
| 2 | +$16.3M | |
| 3 | +$12.3M | |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$9.59M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$8.57M |
Top Sellers
| 1 | -$16.8M | |
| 2 | -$7.33M | |
| 3 | -$7.24M | |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$4.54M |
| 5 |
Squarepoint
New York
|
-$4.49M |
